The (near)equivalence of cost-effectiveness and cost-benefit analyses - Fact or fallacy?

被引:22
|
作者
Donaldson, C [1 ]
机构
[1] Univ Aberdeen, Hlth Econ Res Unit, Aberdeen AB25 2ZD, Scotland
关键词
Adis International Limited; Economic Evaluation; Streptokinase; Alteplase; Advanced Ovarian Cancer;
D O I
10.2165/00019053-199813040-00002
中图分类号
F [经济];
学科分类号
02 ;
摘要
Then has been much recent debate in the health economics literature as to the (near) equivalence of cost-benefit analysis (CBA) and cost-effectiveness analysis (CEA). The aim of this paper is to demonstrate that whether such a (near) equivalence exists depends on whether one defines economic evaluations as 'CBA' or 'CEA' on the basis of either what is measured or what question the analyst is seeking to answer. The former basis of definition is popular within the 'decision science' approach to economic evaluation, but does not seem to have any theoretical support. If the latter, more theoretically correct, basis is accepted, there is no longer a case for the (near) equivalence of CBA and CEA.
引用
收藏
页码:389 / 396
页数:8
相关论文
共 50 条
  • [11] Cost-benefit, cost-effectiveness and cost-utility analyses of periodontitis prevention
    Braegger, U
    JOURNAL OF CLINICAL PERIODONTOLOGY, 2005, 32 : 301 - 313
  • [12] How transfer payments are treated in cost-effectiveness and cost-benefit analyses
    Frisman, L
    Rosenheck, R
    ADMINISTRATION AND POLICY IN MENTAL HEALTH, 1996, 23 (06): : 533 - 546
  • [13] COST-BENEFIT AND COST-EFFECTIVENESS OF THE PFA METHOD
    ENNO, A
    CRAIG, GG
    JOURNAL OF DENTAL RESEARCH, 1980, 59 : 1773 - 1773
  • [14] COST-EFFECTIVENESS AND COST-BENEFIT IN CHOLERA CONTROL
    ABELSMITH, B
    WHO CHRONICLE, 1973, 27 (10) : 407 - 409
  • [15] ATTITUDES AND OPINIONS OF DIETETICS PROFESSIONALS TOWARD COST-BENEFIT AND COST-EFFECTIVENESS ANALYSES
    GILBRIDE, JA
    PARKS, SC
    PALAKURTHI, RR
    JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION, 1994, 94 (04) : 386 - 389
  • [16] Health Economic Studies An Introduction to Cost-benefit, Cost-effectiveness, and Cost-utility Analyses
    Angevine, Peter D.
    Berven, Sigurd
    SPINE, 2014, 39 (22S) : S9 - S15
  • [17] An introduction to cost-effectiveness and cost-benefit analysis of pharmacogenomics
    Phillips, KA
    Veenstra, D
    Van Bebber, S
    Sakowski, J
    PHARMACOGENOMICS, 2003, 4 (03) : 231 - 239
  • [18] Cost-effectiveness and cost-benefit of sumatriptan in patients with migraine
    Lofland, JH
    Kim, SS
    Batenhorst, AS
    Johnson, NE
    Chatterton, ML
    Cady, RK
    Kaniecki, R
    Nash, DB
    MAYO CLINIC PROCEEDINGS, 2001, 76 (11) : 1093 - 1101
  • [19] Limited applicability of cost-effectiveness and cost-benefit analyses for the optimization of radon remedial measures
    Jiranek, Martin
    Rovenska, Katerina
    JOURNAL OF HAZARDOUS MATERIALS, 2010, 182 (1-3) : 439 - 446
  • [20] Congestive heart failure in Spain:: cost-effectiveness and cost-benefit analyses of treatment with β-blockers
    Manglano, JD
    REVISTA CLINICA ESPANOLA, 2005, 205 (04): : 149 - 156